Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

BioLum Sciences - aVenture Company Research

BioLum Sciences

BioLum Sciences

BioLum Sciences develops medical devices for personalized treatments, using advanced bioanalytical chemistry to measure biomarkers in breath and blood for chronic disease management.

Dallas, TX, US🇺🇸

Founded

BioLum Sciences, founded with a mission to revolutionize chronic disease management, specializes in bioanalytical chemistry and medical device development. The company focuses on creating advanced chemical systems to measure biomarkers in exhaled breath condensate and blood samples. Their core analysis platform and chemiluminescent chemistry enable pharmaceutical researchers and clinicians to develop and personalize treatments for conditions such as asthma, COPD, and hypertension.

Notable figures affiliated with BioLum Sciences include leading experts in bioanalytical chemistry and medical device innovation. The company has garnered attention from prominent investors in the healthcare and biotechnology sectors. Key achievements include the successful development of novel assays and diagnostic tools that enhance drug discovery and early disease detection. BioLum Sciences' impact lies in its ability to provide superior detection of reactive oxygen, nitrogen, and sulfur species, thereby propelling critical therapies and improving patient outcomes.

BioLum Sciences - Similar Companies

Biometry

mybiometry.com

eGlint

Boydsense

boydsense.com

Breath Diagnostics

BioLum Sciences - Quick Facts

Who are BioLum Sciences' competitors?

Companies similar to BioLum Sciences include Biometry, eGlint, Boydsense and Breath Diagnostics.

When was BioLum Sciences founded?

BioLum Sciences was founded in 2015.

Where is BioLum Sciences' headquarters located?

BioLum Sciences' headquarters is located in Dallas, TX, US.

When was BioLum Sciences' last funding round?

BioLum Sciences' most recent funding round was for $251.9k (USD) in December 2021.

How much disclosed funding has BioLum Sciences raised?

BioLum Sciences - Classification

Industry: Hardware
Ownership: Private
Technology: Analytics

As of Dec 22, 2021, BioLum Sciences has disclosed funding of $1M (USD). Undisclosed round amounts are excluded.

How many employees does BioLum Sciences have?

BioLum Sciences has 5 employees as of Feb 4, 2024.

Geographic Exposure

United States

Customer: Enterprise
Main Product: Medical Devices

Tags: Consulting
Healthtech

NAICS: 620000Health Care and Social Assistance
SIC: 8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Show 1 more industry code

NAICS: 623000Nursing and Residential Care Facilities

breath-dx.com

Nano Mobile Healthcare

EmitBio

emitbio.com

Biophysical

Prolung

prolunginc.com

ExPrimary

exprimary.com

Profusa

profusa.com

eLum Technologies

Luminostics

IonDX

iondx.com

Lumen Biomedical

lumenbio.com

RedShift BioAnalytics

redshiftbio.com